CN Patent

CN105924444B — Jak抑制剂的晶型及其制备方法

Assigned to Lilai Co · Expires 2019-06-18 · 7y expired

What this patent protects

本发明涉及JAK抑制剂的新晶型及其制备方法。本发明提供的新晶型可用于治疗自身免疫疾病，特别是类风湿性关节炎。本发明提供的新晶型稳定性好，工艺提纯效果显著，且溶解度、引湿性符合药用要求。新晶型的制备方法简单，成本低廉，对未来该药物的优化和开发具有重要价值。

USPTO Abstract

本发明涉及JAK抑制剂的新晶型及其制备方法。本发明提供的新晶型可用于治疗自身免疫疾病，特别是类风湿性关节炎。本发明提供的新晶型稳定性好，工艺提纯效果显著，且溶解度、引湿性符合药用要求。新晶型的制备方法简单，成本低廉，对未来该药物的优化和开发具有重要价值。

Drugs covered by this patent

Patent Metadata

Patent number
CN105924444B
Jurisdiction
CN
Classification
—
Expires
2019-06-18
Drug substance claim
No
Drug product claim
No
Assignee
Lilai Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.